Medicare Enrolled
Dr. Adrian Shandling, MD
Cardiovascular Disease · Los Alamitos, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shandling from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shandling?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shandling
Dr. Adrian Shandling is a cardiovascular disease specialist in Los Alamitos, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Shandling performed 18,460 Medicare services across 11,073 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shandling received a total of $23,988 from 62 pharmaceutical and/or device companies across 1163 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shandling is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in CA
$23,988 industry payments
Medicare Practice Summary
Medicare Utilization ↗18,460
Medicare services
Top 2% in CA for cardiovascular disease
11,073
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~923 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,262 | $105 | $150 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,060 | $7 | $7 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,013 | $12 | $35 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
824 | $7 | $13 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
795 | $8 | $15 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
782 | $10 | $21 |
| Natriuretic peptide level test A blood test that measures the level of natriuretic peptide, a protein produced by the heart and blood vessels. |
782 | $38 | $65 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
769 | $16 | $32 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
740 | $5 | $11 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
730 | $13 | $30 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
722 | $9 | $19 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
714 | $4 | $11 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
697 | $9 | $18 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
644 | $6 | $13 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
637 | $13 | $26 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
476 | $43 | $92 |
| Lipoprotein level test, electrophoretic separation A blood test that separates and measures different types of lipoproteins using electrophoresis. This procedure quantifies specific lipoprotein fractions to assess lipid profiles. |
455 | $11 | $30 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
400 | $2 | $7 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
399 | $5 | $14 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
356 | $171 | $375 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
321 | $68 | $95 |
| High-sensitivity C-reactive protein test A blood test that measures high-sensitivity C-reactive protein to detect infection or inflammation. |
272 | $13 | $25 |
| Heart muscle strain imaging | 260 | $35 | $60 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
248 | $4 | $8 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
232 | $42 | $55 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
230 | $4 | $10 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
204 | $71 | $250 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
192 | $172 | $300 |
| Injection, furosemide, up to 20 mg | 188 | $0 | $2 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
167 | $73 | $110 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
163 | $8 | $16 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
150 | $145 | $200 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
145 | $10 | $20 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
131 | $198 | $375 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
113 | $34 | $45 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
108 | $345 | $670 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
106 | $76 | $95 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
101 | $111 | $160 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
94 | $68 | $97 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
74 | $12 | $41 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
70 | $149 | $230 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
65 | $19 | $41 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
59 | $25 | $40 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
56 | $805 | $1,250 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
51 | $102 | $140 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
47 | $6 | $11 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
42 | $131 | $210 |
| PSA test (prostate cancer screening) | 36 | $18 | $35 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
34 | $1 | $3 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 26 | $417 | $600 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
24 | $156 | $303 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $48 | $75 |
| New patient office visit, complex (60-74 min) | 20 | $182 | $250 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
20 | $21 | $35 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
19 | $22 | $80 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
19 | $87 | $165 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
16 | $11 | $45 |
| SPECT nuclear medicine scan, 1 area A nuclear medicine imaging test using a single photon emission computed tomography (SPECT) scan to create detailed images of one specific area of the body. |
15 | $301 | $500 |
| Technetium Tc-99m pyrophosphate diagnostic injection A diagnostic injection of Technetium Tc-99m pyrophosphate used for imaging studies. The dose administered is up to 25 millicuries. |
15 | $46 | $75 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
12 | $1,667 | $3,000 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
12 | $99 | $500 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
12 | $64 | $200 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
11 | $25 | $52 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.9% high complexity
9.4% medium
87.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$23,988
Total received (2018-2024)
Avg $3,427/year across 7 years
Top 15% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
1,163
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,342 (97.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$646 (2.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,254
2023
$2,777
2022
$3,109
2021
$2,645
2020
$4,014
2019
$4,014
2018
$3,174
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$1,439
Novartis Pharmaceuticals Corporation
$351
AstraZeneca Pharmaceuticals LP
$319
Merck Sharp & Dohme LLC
$319
Boehringer Ingelheim Pharmaceuticals, Inc.
$285
Novo Nordisk Inc
$239
Janssen Pharmaceuticals, Inc
$203
ATRICURE, INC.
$172
PFIZER INC.
$153
Actelion Pharmaceuticals US, Inc.
$131
Kiniksa Pharmaceuticals International, plc
$119
Alnylam Pharmaceuticals Inc.
$83
SCPHARMACEUTICALS INC.
$75
Amgen Inc.
$57
E.R. Squibb & Sons, L.L.C.
$56
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$45
Boston Scientific Corporation
$44
Bayer Healthcare Pharmaceuticals Inc.
$40
Celgene Corporation
$39
Lexicon Pharmaceuticals, Inc.
$28
United Therapeutics Corporation
$28
Regeneron Healthcare Solutions, Inc.
$27
Top 3 companies account for 49.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,197
Medtronic Vascular, Inc.
$1,766
Medtronic, Inc.
$1,649
SANOFI-AVENTIS U.S. LLC
$1,595
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,351
Amgen Inc.
$1,280
Janssen Pharmaceuticals, Inc
$1,238
PFIZER INC.
$1,165
AstraZeneca Pharmaceuticals LP
$977
Novo Nordisk Inc
$798
E.R. Squibb & Sons, L.L.C.
$754
Merck Sharp & Dohme LLC
$752
Alnylam Pharmaceuticals Inc.
$674
Regeneron Healthcare Solutions, Inc.
$610
United Therapeutics Corporation
$577
Kowa Pharmaceuticals America, Inc.
$547
Medicure Pharma Inc.
$546
Gilead Sciences, Inc.
$442
Esperion Therapeutics, Inc.
$413
Amarin Pharma Inc.
$387
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$353
Biosense Webster, Inc.
$298
Bayer HealthCare Pharmaceuticals Inc.
$298
Actelion Pharmaceuticals US, Inc.
$296
Boston Scientific Corporation
$241
AtriCure, Inc.
$227
ATRICURE, INC.
$194
Lundbeck LLC
$189
Allergan Inc.
$180
Akcea Therapeutics, Inc.
$167
Merck Sharp & Dohme Corporation
$159
iRhythm Technologies, Inc.
$156
Impulse Dynamics (USA) Inc.
$127
Kiniksa Pharmaceuticals International, plc
$119
Bardy Diagnostics, Inc.
$118
Philips Electronics North America Corporation
$112
Bayer Healthcare Pharmaceuticals Inc.
$111
SCPHARMACEUTICALS INC.
$92
Medical Device Business Services, Inc.
$82
Kestra Medical Technology Services, Inc.
$79
Kiniksa Pharmaceuticals, Ltd.
$72
Abbott Laboratories
$70
PORTOLA PHARMACEUTICALS, INC.
$55
Circassia Pharmaceuticals Inc
$46
GlaxoSmithKline, LLC.
$42
Celgene Corporation
$39
BOSTON SCIENTIFIC CORPORATION
$36
ARBOR PHARMACEUTICALS, INC.
$36
BIOTRONIK INC.
$30
Lexicon Pharmaceuticals, Inc.
$28
Sobi, Inc
$25
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$24
Eisai Inc.
$23
Takeda Pharmaceuticals U.S.A., Inc.
$21
Alexion Pharmaceuticals, Inc.
$20
GENZYME CORPORATION
$17
W. L. Gore & Associates, Inc.
$16
Edwards Lifesciences Corporation
$15
Regeneron Pharmaceuticals, Inc.
$15
LeMaitre Vascular, Inc.
$15
Daiichi Sankyo Inc.
$15
CMP Pharma, Inc.
$13
Top 3 companies account for 23.4% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (7999) SRC Undivided · AMVUTTRA · ANDEXXA · ASSURITY · ATRICLIP LAA EXCLUSION SYSTEM · Aimovig · Andexxa · Arcalyst · Arctic Front · Assure WCD · AtriCure Synergy Ablation System · BELSOMRA · BEVYXXA · BRILINTA · BYSTOLIC · CAMZYOS · CARTO 3 · CHANTIX · COBALT DR MRI SURESCAN · CardioMEMS HF System · Carnation Ambulatory Monitor · Carospir · Carto 3 · Carto 3 System · Confidense · Corlanor · Dayvigo · ELIQUIS · ENTRESTO · EVKEEZA · Edarbi · Edora 8 DR-T · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Epi-Sense Guided Coagulation System with VisiTrax · FABRY-DISEASE · FARXIGA · FUROSCIX · GORE CARDIOFORM Septal Occluder · General - Therapies · HMG-CoA reductase inhibitor. · INJECTAFER · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LUX DX · LUX-Dx Insertable Cardiac Monitor · Letairis · LifeVest · Livalo · MICRA · MULTAQ · Mitra Clip system · Models · NA · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · ORENITRAM · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PULSESELECT · RELISTOR ORAL · RESONATE · RESTOREFLO · Repatha · Reveal LINQ · Rivacor · S-ICD System Magnet · SHINGRIX · STEGLATRO · TEGSEDI · TUDORZA PRESSAIR · TYVASO · Trintellix · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · WAINUA · WATCHMAN Access System · WATCHMAN FLX · WINREVAIR · XARELTO · ZIO Patch · ZIO XT Patch · ZYPITAMAG · Zephyr Pacemaker
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
407
Per 100K population
12.9
County median income
$113,702
Nearest hospital
UCI HEALTH - LOS ALAMITOS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shandling is a mixed practice specialist, with above-average Medicare volume (top 2% in CA), with low-engagement industry engagement in the top 15% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shandling experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Shandling performed 1,262 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shandling receive payments from pharmaceutical companies?
Yes. Dr. Shandling received a total of $23,988 from 62 companies across 1,163 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shandling's costs compare to other cardiologists in Los Alamitos?
Dr. Shandling's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shandling) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Los Alamitos
Browse cardiologists in Los Alamitos ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology